What are the potential interactions between domperidone and propranolol (beta-blocker)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Domperidone and Propranolol Drug Interaction

The combination of domperidone and propranolol carries significant cardiac risk due to additive QTc prolongation effects and should be avoided or used with extreme caution with mandatory ECG monitoring. 1

Primary Cardiac Concerns

QTc Prolongation Risk

  • Domperidone prolongs the QTc interval and requires long-term ECG monitoring when used chronically, as highlighted by National Patient Safety Agency alerts 1
  • Propranolol, as a non-selective beta-blocker, can also affect cardiac conduction and rhythm 1
  • The combination creates additive risk for potentially fatal cardiac arrhythmias, similar to the mechanism that led to cisapride's withdrawal from the market 1

Hemodynamic Complications

  • Beta-blockers like propranolol can cause bradycardia, hypotension, and cardiac conduction abnormalities 2, 3
  • When combined with domperidone's QTc effects, patients face compounded risk of serious arrhythmias
  • This interaction is particularly dangerous in patients with pre-existing cardiac conditions, electrolyte abnormalities, or those taking other QT-prolonging medications 1

Clinical Management Algorithm

Before Prescribing This Combination:

  • Obtain baseline ECG to assess QTc interval - do not proceed if QTc >450 ms in men or >470 ms in women 1
  • Check serum electrolytes (potassium, magnesium, calcium) and correct any abnormalities before initiating therapy 1
  • Review all concurrent medications for additional QTc-prolonging agents 1
  • Assess cardiac history including arrhythmias, heart failure, or structural heart disease 4

If Combination is Unavoidable:

  • Use the lowest effective doses of both medications 1
  • Perform ECG monitoring at baseline, after 1 week, and then monthly during chronic therapy 1
  • Monitor for symptoms of excessive beta-blockade: dizziness, fatigue, syncope, or bradycardia 4
  • Consider cardiology consultation for high-risk patients 4

Safer Alternatives

Instead of Domperidone:

  • Consider prucalopride (selective 5-HT4 agonist) which does not affect QT interval and has no significant cardiac risks 1
  • Erythromycin or azithromycin may be options for small bowel dysmotility, though subject to tachyphylaxis 1

Instead of Propranolol:

  • If beta-blockade is needed for tremor or anxiety, consider whether the indication truly requires propranolol or if non-pharmacological approaches could suffice 2
  • For cardiac indications, cardioselective beta-blockers like metoprolol may have slightly different risk profiles, though caution remains warranted 5, 6

Critical Pitfalls to Avoid

  • Never assume domperidone is safe for long-term use without ECG monitoring - this is a common prescribing error 1
  • Do not overlook drug-drug interactions with CYP2D6 inhibitors (certain antidepressants) that can increase propranolol levels and toxicity 7
  • Avoid abrupt discontinuation of propranolol after regular use, as rebound symptoms can occur 2, 3
  • Remember that propranolol can mask hypoglycemia symptoms in diabetic patients, adding another layer of risk 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Propranolol for Stage Fright

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Propranolol and Depression: Mechanism and Evidence

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Concurrent Use of Propranolol and Metoprolol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Which of these medications can exacerbate tremors: alendronate (70 mg tablet), Botox (100 unit injection) (botulinum toxin), bupropion HCl SR (100 mg tablet, 12-hour sustained-release), clonidine HCl (0.1 mg tablet), dextroamphetamine-amphetamine (10 mg tablet), etodolac (400 mg tablet), fluoxetine (10 mg and 20 mg capsules), gabapentin (100 mg capsule), levetiracetam (750 mg tablet), lorazepam (0.5 mg tablet), multivitamin, and vitamin D?
Are there any interactions between Austedo (deutetrabenazine) and verapamil?
What safety and management recommendations are appropriate for a patient taking atorvastatin 40 mg nightly, bupropion XL 300 mg daily, clonazepam 0.5 mg nightly (taper to 0.25 mg then discontinue), duloxetine 120 mg daily, estradiol 0.5 mg nightly, ferrous sulfate (Palafer) 300 mg daily, hydromorphone immediate‑release 3 mg every 4 h and controlled‑release 9 mg every 8 h, insulin degludec 90 units subcutaneously daily, insulin glulisine 32 units three times daily with meals, lactulose 30 g three times daily, linagliptin 5 mg daily, mirtazapine 30 mg nightly, multivitamin, pantoprazole 40 mg each morning before breakfast, pregabalin 75 mg twice daily, probiotic (Florastor) 2.5 billion CFU twice daily, sodium bicarbonate 1000 mg three times daily, and zopiclone 7.5 mg nightly?
Are there any significant interactions between propranolol (beta-blocker) and duloxetine (antidepressant)?
Is it safe to use albuterol (beta-2 agonist) with modafinil (wakefulness promoter) and propranolol (beta-blocker) together?
What should be done if bleeding occurs during continuous natural progesterone (micronized progesterone) administration via vaginal route at 200 mg daily?
What is the recommended treatment for moderate dehydration?
How to manage steroid-induced capillary bleeding?
What is the recommended IV hydration regimen for a patient with moderate signs of dehydration?
What is the treatment for osteopenia?
How to manage pruritus in a patient with chronic liver disease (CLD) and hepatocellular carcinoma (HCC) who is experiencing pruritus while on opioids?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.